tiprankstipranks
Rigel Pharmaceuticals (RIGL)
NASDAQ:RIGL
US Market
Want to see RIGL full AI Analyst Report?

Rigel (RIGL) Ratios

1,604 Followers

Rigel Ratios

RIGL's free cash flow for Q1 2026 was $0.92. For the 2026 fiscal year, RIGL's free cash flow was decreased by $ and operating cash flow was $0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.62 2.42 2.13 1.86 1.78
Quick Ratio
2.48 2.30 2.04 1.76 1.64
Cash Ratio
0.27 0.41 0.90 0.62 0.38
Solvency Ratio
3.50 3.03 0.12 -0.16 -0.39
Operating Cash Flow Ratio
0.89 0.76 0.50 -0.11 -1.13
Short-Term Operating Cash Flow Coverage
2.60 2.49 4.33 -0.79 0.00
Net Current Asset Value
$ 129.32M$ 118.05M$ -25.59M$ -46.60M$ -31.99M
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.10 0.37 0.52 0.31
Debt-to-Equity Ratio
0.11 0.14 18.24 -2.11 -3.05
Debt-to-Capital Ratio
0.10 0.12 0.95 1.90 1.49
Long-Term Debt-to-Capital Ratio
0.04 0.06 0.94 2.21 1.53
Financial Leverage Ratio
1.26 1.31 49.87 -4.09 -9.86
Debt Service Coverage Ratio
9.99 9.98 1.82 -1.20 -14.53
Interest Coverage Ratio
18.05 17.14 3.06 -2.98 -14.99
Debt to Market Cap
0.09 0.07 0.20 0.24 0.15
Interest Debt Per Share
2.86 3.37 3.86 3.88 2.63
Net Debt to EBITDA
0.16 0.10 0.11 -1.64 -0.32
Profitability Margins
Gross Profit Margin
93.39%93.33%89.60%93.92%98.55%
EBIT Margin
42.99%43.89%14.66%-15.59%-45.63%
EBITDA Margin
43.79%44.71%15.90%-14.53%-44.80%
Operating Profit Margin
41.56%42.63%13.49%-17.53%-46.20%
Pretax Profit Margin
40.69%41.40%10.24%-21.47%-48.71%
Net Profit Margin
121.51%124.72%9.75%-21.47%-48.71%
Continuous Operations Profit Margin
121.51%124.72%9.75%-21.47%-48.71%
Net Income Per EBT
298.62%301.27%95.20%100.00%100.00%
EBT Per EBIT
97.91%97.10%75.92%122.45%105.44%
Return on Assets (ROA)
72.18%71.46%10.66%-21.40%-43.62%
Return on Equity (ROE)
147.03%93.75%531.78%87.60%430.18%
Return on Capital Employed (ROCE)
30.01%30.28%24.03%-32.04%-80.43%
Return on Invested Capital (ROIC)
27.96%28.21%21.28%-28.51%-79.13%
Return on Tangible Assets
75.81%75.08%12.77%-24.28%-49.08%
Earnings Yield
69.14%47.64%5.91%-9.94%-22.65%
Efficiency Ratios
Receivables Turnover
6.00 5.69 4.31 3.83 2.98
Payables Turnover
4.42 2.73 5.58 1.00 0.08
Inventory Turnover
1.70 1.71 3.11 1.29 0.19
Fixed Asset Turnover
381.87 319.87 530.41 113.92 43.14
Asset Turnover
0.59 0.57 1.09 1.00 0.90
Working Capital Turnover Ratio
2.10 2.77 3.04 2.42 1.70
Cash Conversion Cycle
192.79 144.47 136.85 12.24 -2.67K
Days of Sales Outstanding
60.81 64.20 84.73 95.40 122.39
Days of Inventory Outstanding
214.60 214.04 117.48 283.48 1.90K
Days of Payables Outstanding
82.62 133.77 65.36 366.64 4.70K
Operating Cycle
275.42 278.24 202.21 378.88 2.03K
Cash Flow Ratios
Operating Cash Flow Per Share
4.31 4.21 1.79 -0.33 -4.28
Free Cash Flow Per Share
4.31 4.21 1.77 -1.19 -4.30
CapEx Per Share
0.00 0.00 0.02 0.86 0.03
Free Cash Flow to Operating Cash Flow
1.00 1.00 0.99 3.61 1.01
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 79.47 -0.38 -163.91
Capital Expenditure Coverage Ratio
0.00 0.00 79.47 -0.38 -163.91
Operating Cash Flow Coverage Ratio
1.73 1.42 0.52 -0.09 -1.78
Operating Cash Flow to Sales Ratio
0.26 0.26 0.18 -0.05 -0.61
Free Cash Flow Yield
14.98%9.82%10.51%-8.22%-28.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
1.45 2.10 16.91 -10.06 -4.42
Price-to-Sales (P/S) Ratio
1.77 2.62 1.65 2.16 2.15
Price-to-Book (P/B) Ratio
1.32 1.97 89.93 -8.81 -18.99
Price-to-Free Cash Flow (P/FCF) Ratio
6.68 10.18 9.52 -12.16 -3.48
Price-to-Operating Cash Flow Ratio
6.64 10.18 9.40 -43.93 -3.51
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 -0.10 0.17 -0.02
Price-to-Fair Value
1.32 1.97 89.93 -8.81 -18.99
Enterprise Value Multiple
4.19 5.95 10.48 -16.50 -5.12
Enterprise Value
550.65M 783.11M 298.90M 280.11M 275.70M
EV to EBITDA
4.19 5.95 10.48 -16.50 -5.12
EV to Sales
1.84 2.66 1.67 2.40 2.29
EV to Free Cash Flow
6.95 10.35 9.62 -13.50 -3.72
EV to Operating Cash Flow
6.95 10.35 9.50 -48.77 -3.74
Tangible Book Value Per Share
20.41 20.39 -1.35 -2.44 -1.66
Shareholders’ Equity Per Share
21.72 21.76 0.19 -1.65 -0.79
Tax and Other Ratios
Effective Tax Rate
-1.99 -2.01 0.05 0.00 0.00
Revenue Per Share
16.28 16.36 10.20 6.72 6.97
Net Income Per Share
19.78 20.40 0.99 -1.44 -3.40
Tax Burden
2.99 3.01 0.95 1.00 1.00
Interest Burden
0.95 0.94 0.70 1.38 1.07
Research & Development to Revenue
0.12 0.11 0.13 0.21 0.50
SG&A to Revenue
0.40 0.39 0.63 0.00 0.00
Stock-Based Compensation to Revenue
0.04 0.04 0.07 0.08 0.10
Income Quality
0.22 0.21 1.80 0.23 1.26
Currency in USD